These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 34132177)
1. In Vitro Evaluation of Immunogenicity of Recombinant OMP25 Protein Obtained from Endemic Brucella abortus Biovar 3 as Vaccine Candidate Molecule Against Animal Brucellosis. Atabey T; Acar T; Derman S; Ordu E; Erdemir A; Taşlı PN; Gür GK; Şahin F; Güllüce M; Arasoğlu T Protein Pept Lett; 2021; 28(10):1138-1147. PubMed ID: 34132177 [TBL] [Abstract][Full Text] [Related]
2. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ. Paul S; Peddayelachagiri BV; Nagaraj S; Konduru B; Batra HV Appl Microbiol Biotechnol; 2018 Oct; 102(20):8895-8907. PubMed ID: 30136204 [TBL] [Abstract][Full Text] [Related]
3. Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544. Goel D; Bhatnagar R Mol Immunol; 2012 Jun; 51(2):159-68. PubMed ID: 22464098 [TBL] [Abstract][Full Text] [Related]
4. Brucella abortus antigen omp25 vaccines: Development and targeting based on Lactococcus lactis. Gouran ST; Doosti A; Jami MS Vet Med Sci; 2023 Jul; 9(4):1908-1922. PubMed ID: 37276346 [TBL] [Abstract][Full Text] [Related]
5. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis. Gupta S; Singh D; Gupta M; Bhatnagar R Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564 [TBL] [Abstract][Full Text] [Related]
6. Construction of recombinant Omp25 or EipB protein loaded PLGA nanovaccines for Brucellosis protection. Akmayan I; Oztav S; Coksu I; Abamor ES; Acar S; Ozbek T Nanotechnology; 2024 Jul; 35(39):. PubMed ID: 38917779 [TBL] [Abstract][Full Text] [Related]
7. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544. Goel D; Rajendran V; Ghosh PC; Bhatnagar R Vaccine; 2013 Feb; 31(8):1231-7. PubMed ID: 23273966 [TBL] [Abstract][Full Text] [Related]
8. Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis. Vrushabhendrappa ; Singh AK; Balakrishna K; Sripathy MH; Batra HV Vaccine; 2014 Sep; 32(43):5600-6. PubMed ID: 25131740 [TBL] [Abstract][Full Text] [Related]
9. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model. Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective response induced by recombinant Brucella abortus proteins Adk, SecB and combination of these two recombinant proteins against a virulent strain B. abortus 544 infection in BALB/c mice. Huy TXN; Bernardo Reyes AW; Vu SH; Arayan LT; Hop HT; Min W; Lee HJ; Lee JH; Kim S Microb Pathog; 2020 Jun; 143():104137. PubMed ID: 32169487 [TBL] [Abstract][Full Text] [Related]
11. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice. Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous Immunization with Omp25 and L7/L12 Provides Protection against Brucellosis in Mice. Gupta S; Mohan S; Somani VK; Aggarwal S; Bhatnagar R Pathogens; 2020 Feb; 9(2):. PubMed ID: 32102449 [TBL] [Abstract][Full Text] [Related]
13. Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection. Tabynov K; Sansyzbay A; Kydyrbayev Z; Yespembetov B; Ryskeldinova S; Zinina N; Assanzhanova N; Sultankulova K; Sandybayev N; Khairullin B; Kuznetsova I; Ferko B; Egorov A Virol J; 2014 Apr; 11():69. PubMed ID: 24716528 [TBL] [Abstract][Full Text] [Related]
14. Identification of novel drug targets for humans and potential vaccine targets for cattle by subtractive genomic analysis of Brucella abortus strain 2308. Mahmud A; Khan MT; Iqbal A Microb Pathog; 2019 Dec; 137():103731. PubMed ID: 31509762 [TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of Omp19 and Omp25 proteins for designing multi-epitope vaccines against Brucella. Shi D; Chen Y; Chen M; Zhou T; Xu F; Zhang C; Wang C; Li Z Medicine (Baltimore); 2023 Mar; 102(11):e33182. PubMed ID: 36930131 [TBL] [Abstract][Full Text] [Related]
16. A novel Omp25-binding peptide screened by phage display can inhibit Brucella abortus 2308 infection in vitro and in vivo. Zhang J; Guo F; Huang X; Chen C; Liu R; Zhang H; Wang Y; Yin S; Li Z J Med Microbiol; 2014 Jun; 63(Pt 6):780-787. PubMed ID: 24722798 [TBL] [Abstract][Full Text] [Related]
17. Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides. Kaushik P; Singh DK; Kumar SV; Tiwari AK; Shukla G; Dayal S; Chaudhuri P Vet Res Commun; 2010 Feb; 34(2):119-32. PubMed ID: 20013309 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of Th1/Th2-Related Immune Response against Recombinant Proteins of Brucella abortus Infection in Mice. Im YB; Park WB; Jung M; Kim S; Yoo HS J Microbiol Biotechnol; 2016 Jun; 26(6):1132-9. PubMed ID: 27012238 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and protective efficacy of Brucella abortus recombinant protein cocktail (rOmp19+rP39) against B. abortus 544 and B. melitensis 16M infection in murine model. Tadepalli G; Singh AK; Balakrishna K; Murali HS; Batra HV Mol Immunol; 2016 Mar; 71():34-41. PubMed ID: 26826463 [TBL] [Abstract][Full Text] [Related]
20. Comparative Analysis of Immune Responses to Outer Membrane Antigens OMP10, OMP19, and OMP28 of Brucella abortus. Im YB; Park WB; Jung M; Kim S; Yoo HS Jpn J Infect Dis; 2018 May; 71(3):197-204. PubMed ID: 29709972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]